|
|
||||||||
CUTTING EDGE |


Departments of
*
Neurology and
Medical and Molecular Pharmacology, UCLA School of Medicine, Los Angeles, CA 90095
We used an antisense oligodeoxynucleotide (ODN) complementary to inducible nitric oxide synthase (iNOS) to inhibit experimental autoimmune encephalomyelitis (EAE) in female SJL/J mice, an animal model for multiple sclerosis. The antisense ODN was administered intraventricularly to mice daily for 10 days beginning at the time of adoptive transfer of myelin basic protein-specific T lymphocytes. The antisense ODN treatment significantly reduced the clinical score of EAE and blocked iNOS mRNA and protein synthesis, as well as iNOS enzyme activity within the central nervous system. The levels of nitric oxide and cyclic guanosine monophosphate were also significantly reduced by the antisense ODN treatment. Neither sense nor random ODN affected clinical EAE or iNOS expression. Moreover, the protein and enzyme activity level of constitutive neuronal nitric oxide synthase was not affected by the antisense ODN. Thus, we have shown that the iNOS antisense ODN specifically blocked iNOS expression and ameliorated the induction of EAE.
This article has been cited by other articles:
![]() |
S. Ling, X. Pi, and J. Holoshitz The Rheumatoid Arthritis Shared Epitope Triggers Innate Immune Signaling via Cell Surface Calreticulin J. Immunol., November 1, 2007; 179(9): 6359 - 6367. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, A. Roy, M. Jana, D. M. Hartley, and K. Pahan Gemfibrozil Ameliorates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Independent of Peroxisome Proliferator-Activated Receptor-{alpha} Mol. Pharmacol., October 1, 2007; 72(4): 934 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Paintlia, M. K. Paintlia, I. Singh, and A. K. Singh IL-4-Induced Peroxisome Proliferator-Activated Receptor {gamma} Activation Inhibits NF-{kappa}B Trans Activation in Central Nervous System (CNS) Glial Cells and Protects Oligodendrocyte Progenitors under Neuroinflammatory Disease Conditions: Implication for CNS-Demyelinating Diseases J. Immunol., April 1, 2006; 176(7): 4385 - 4398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, Y. Zhou, M. Jana, N. L. Banik, and K. Pahan Sodium Phenylacetate Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis in SJL/J Mice at Multiple Steps J. Immunol., April 1, 2003; 170(7): 3874 - 3882. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, M. Jana, X. Liu, and K. Pahan Myelin Basic Protein-primed T Cells Induce Nitric Oxide Synthase in Microglial Cells. IMPLICATIONS FOR MULTIPLE SCLEROSIS J. Biol. Chem., October 11, 2002; 277(42): 39327 - 39333. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Arnett, R. P. Hellendall, G. K. Matsushima, K. Suzuki, V. E. Laubach, P. Sherman, and J. P.-Y. Ting The Protective Role of Nitric Oxide in a Neurotoxicant- Induced Demyelinating Model J. Immunol., January 1, 2002; 168(1): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. I. Austenaa and A. C. Ross Potentiation of interferon-{gamma}-stimulated nitric oxide production by retinoic acid in RAW 264.7 cells J. Leukoc. Biol., July 1, 2001; 70(1): 121 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Y. Xu, J.-S. Yang, H. Link, and B.-G. Xiao SIN-1, a Nitric Oxide Donor, Ameliorates Experimental Allergic Encephalomyelitis in Lewis Rats in the Incipient Phase: The Importance of the Time Window J. Immunol., May 1, 2001; 166(9): 5810 - 5816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Drulovic, I Dujmovic, S Mesaros, T Samardzic, D Maksimovic, N Stojsavljevic, Z Levic, and M M. Stojkovic Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity Multiple Sclerosis, February 1, 2001; 7(1): 19 - 22. [Abstract] [PDF] |
||||
![]() |
M. Hesse, A. W. Cheever, D. Jankovic, and T. A. Wynn NOS-2 Mediates the Protective Anti-Inflammatory and Antifibrotic Effects of the Th1-Inducing Adjuvant, IL-12, in a Th2 Model of Granulomatous Disease Am. J. Pathol., September 1, 2000; 157(3): 945 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Heeger, T. Forsthuber, C. Shive, E. Biekert, C. Genain, H. H. Hofstetter, A. Karulin, and P. V. Lehmann Revisiting Tolerance Induced by Autoantigen in Incomplete Freund's Adjuvant J. Immunol., June 1, 2000; 164(11): 5771 - 5781. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. van der Veen, T. A. Dietlin, F. M. Hofman, L. Pen, B. H. Segal, and S. M. Holland Superoxide Prevents Nitric Oxide-Mediated Suppression of Helper T Lymphocytes: Decreased Autoimmune Encephalomyelitis in Nicotinamide Adenine Dinucleotide Phosphate Oxidase Knockout Mice J. Immunol., May 15, 2000; 164(10): 5177 - 5183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bogdan The Multiplex Function of Nitric Oxide in (Auto)immunity J. Exp. Med., May 4, 1998; 187(9): 1361 - 1365. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |